• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Modular Medical Inc. (Amendment)

    2/28/22 4:55:46 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care
    Get the next $MODD alert in real time by email
    SC 13D/A 1 d9396295_13d-a.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13D

    THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 5)*

     

     

    Modular Medical, Inc.
    (Name of Issuer)

     

     

    Common Stock, par value $0.001 per share
    (Title of Class of Securities)

     

     

    60785L108
    (CUSIP Number)

     

     

    James E. Besser

    c/o Manchester Management Company, LLC

    2 Calle Candina, #1701

    San Juan, Puerto Rico, 00907

    Telephone Number: (617) 399-1741

    (Name, Address and Telephone Number of Person Authorized to Receive

    Notices and Communications)

     

     

    February 23, 2022
    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [  ].
       

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Manchester Management PR, LLC  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      AF  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Puerto Rico  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      3,189,061  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARED DISPOSITIVE POWER  
         
      3,189,061  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      3,189,061  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      28.9%  

     

    14. TYPE OF REPORTING PERSON  
         
      IA  
         

     

     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Manchester Explorer, L.P.  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      2,871,588    

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARED DISPOSITIVE POWER  
         
      2,871,588    

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      2,871,588    

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      26.0%  

     

    14. TYPE OF REPORTING PERSON  
         
      PN  
         

     

     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      JEB Partners, L.P.  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      317,473    

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARED DISPOSITIVE POWER  
         
      317,473    

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      317,473    

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      3.1%  

     

    14. TYPE OF REPORTING PERSON  
         
      PN  
         

     

     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Manchester Management Company, LLC  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      AF  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      3,189,061  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARED DISPOSITIVE POWER  
         
      3,189,061  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      3,189,061  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      28.9%  

     

    14. TYPE OF REPORTING PERSON  
         
      OO  
         
     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      James E. Besser  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      AF  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      United States of America  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      124,750  

     

    8. SHARED VOTING POWER  
         
      3,189,061  

     

    9. SOLE DISPOSITIVE POWER
         
      124,750  

     

    10. SHARED DISPOSITIVE POWER  
         
      3,189,061  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      3,313,811  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      30.0%  

     

    14. TYPE OF REPORTING PERSON  
         
      IN  
         

     

     
     

     

    CUSIP No. 60785L108    

      

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Morgan C. Frank  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)  [_]
        (b)  [_]

      

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      AF  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
    [_]

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      United States of America  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7. SOLE VOTING POWER  
         
      128,173 (1)  

     

    8. SHARED VOTING POWER  
         
      2,871,588    

     

    9. SOLE DISPOSITIVE POWER
         
      128,173 (1)  

     

    10. SHARED DISPOSITIVE POWER  
         
      2,871,588    

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      2,999,761  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  
    [_]

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      27.0%  

     

    14. TYPE OF REPORTING PERSON  
         
      IN  
     

     

     

     

     

    (1) As a result of options granted to the Reporting Person, the Reporting Person currently has aggregate options to purchase a total of 67,896 shares of the Issuer.

     

     

     
     

     

    CUSIP No. 60785L108    

      

    Item 1. Security and Issuer.  

     

      The name of the issuer is Modular Medical, Inc., a Nevada corporation (the "Issuer").  The address of the Issuer's principal executive offices is 16772 W. Bernardo Drive, San Diego, California 92127.  This Schedule 13D relates to the Issuer's Common Stock, par value $0.001 per share (the "Shares").  
         
         

     

     

    Item 2. Identity and Background.  

     

      (a), (f) This Schedule 13D is being filed jointly by Manchester Management PR, LLC, a Puerto Rican limited liability company (“Manchester”), Manchester Explorer, L.P., a Delaware limited partnership (the “Explorer”), JEB Partners, L.P., a Delaware limited partnership (the “Jeb Partners”), Manchester Management Company, LLC, a Delaware limited liability company (the “GP”), James E. Besser (“Besser”), a United States citizen and Morgan C. Frank (“Frank”), a United States citizen (collectively, the "Reporting Persons").    
           
      (b) The principal business address for each of the Reporting Persons is 2 Calle Candina, #1701, San Juan, Puerto Rico, 00907.  
           
      (c) Besser is the managing member of Manchester and the GP and Frank serves as a portfolio manager and as a consultant for Explorer.  The principal business of Manchester is serving as an investment adviser to its clients.  The principal business of the GP is serving as the general partner to certain private funds.  Manchester is the investment manager to Explorer and Jeb Partners and the GP is the general partner of Explorer and Jeb Partners.  The principal business of each of Explorer and Jeb Partners is purchasing, holding and selling securities for investment purposes.  
           
      (d), (e) During the last five years, none of the Reporting Persons has been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.  The Reporting Persons disclaim membership in a group.    
           
         

     

     
     

     

    Item 3. Source and Amount of Funds or Other Consideration.  
         
      The funds for the purchase of the Shares for each of Besser and Frank came from their personal funds (and director compensation with respect to Frank) and from the working capital of Explorer and Jeb Partners, over which the Reporting Persons, through their roles described above in Item 2(c), exercise investment discretion.  No borrowed funds were used to purchase the Shares, other than borrowed funds used for working capital purposes in the ordinary course of business.      
         

     

     

    Item 4. Purpose of Transaction.  
         
     

    On February 23, 2022, James E. Besser was appointed Chief Executive Officer of the Issuer. Other than the foregoing, there have been no material changes to Item 4 of the Schedule 13D/A filed by the Reporting Persons on February 17, 2022.

     

     
         

     

     

    Item 5. Interest in Securities of the Issuer.  
         

     

      (a) - (e)

    Besser:

    As of the date hereof, Besser may be deemed to be the beneficial owner of 3,313,811 Shares, constituting 30.0% of the Shares*.

     

    Besser has the sole power to vote or direct the vote of 124,750 Shares; has the shared power to vote or direct the vote of 3,189,061 Shares; has the sole power to dispose or direct the disposition of 124,750 Shares; and has the shared power to dispose or direct the disposition of 3,189,061 Shares.

     

    Frank:

    As of the date hereof, Frank may be deemed to be the beneficial owner of 2,999,761 Shares, constituting 27.0% of the Shares*.

     

    Frank has the sole power to vote or direct the vote of 128,173 Shares; has the shared power to vote or direct the vote of 2,871,588 Shares; has the sole power to dispose or direct the disposition of 128,173 Shares; and has the shared power to dispose or direct the disposition of 2,871,588 Shares.

     

    Manchester and GP:

    As of the date hereof, Manchester and the GP may be deemed to be the beneficial owner of 3,189,061 Shares, constituting 28.9% of the Shares*.

     

    Manchester and the GP have the sole power to vote or direct the vote of 0 Shares; have the shared power to vote or direct the vote of 3,189,061 Shares; have the sole power to dispose or direct the disposition of 0 Shares; and have the shared power to dispose or direct the disposition of 3,189,061 Shares.

     

    Explorer:

    As of the date hereof, Explorer may be deemed to be the beneficial owner of 2,871,588 Shares, constituting 26.0% of the Shares*.

     

    Explorer has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 2,871,588 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 2,871,588 Shares.

     

    Jeb Partners:

    As of the date hereof, Jeb Partners may be deemed to be the beneficial owner of 317,473 Shares, constituting 3.1% of the Shares*.

     

    Jeb Partners has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 317,473 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 317,473 Shares.

     

    The transactions by the Reporting Persons in the Shares since the Schedule 13D/A filed by the Reporting Persons on February 14, 2022 are set forth in Exhibit B. All such transactions were carried out in open market transactions.

     

    *The outstanding Shares figure reflects 10,401,648 Shares outstanding as reported in the Issuer’s 424B4 filed by the Issuer on February 11, 2022.

     
           

     

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.  
         
      There have been no changes to Item 6 of the disclosure in the Schedule 13D/A filed by the Reporting Persons on February 17, 2022.  
         

     

    Item 7. Material to be Filed as Exhibits.  

     

     

    Exhibit A: Joint Filing Agreement

    Exhibit B: Schedule of Transactions in Shares

         
     
     

     

     

    SIGNATURE

     

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

        February 28, 2022  
       

    (Date)

     

     

     

     

    MANCHESTER EXPLORER, L.P.*   /s/ James E. Besser (Signature)     James E. Besser, Managing Member of the General Partner (Name/Title)   Manchester Management Company, LLC*   /s/ James E. Besser
      (Signature)
       
       
      James E. Besser, Managing Member
      (Name/Title)
               

     

      Manchester Management PR, LLC*   /s/ James E. Besser (Signature)     James E. Besser, Managing Member (Name/Title)  
      JAMES E. BESSER
       
      /s/ James E. Besser
     

    (Signature)

     

    MORGAN C. FRANK

     

    /s/ Morgan C. Frank

    (Signature)

     

    * This reporting person disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that any such person is the

    beneficial owner of these securities for purposes of Section 16 of the U.S. Securities Exchange Act of 1934, as amended, or for any other purpose.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 10001).

     

     
     

     

     

    Exhibit A

     

     

    AGREEMENT

     

     

    The undersigned agree that this Schedule 13D amendment, dated February 28, 2022, relating to the Common Stock, par value $0.001 per share, of Modular Medical, Inc. shall be filed on behalf of the undersigned.

     

          February 28, 2022  
          (Date)  

     

     

     

    MANCHESTER EXPLORER, L.P.*   /s/ James E. Besser (Signature)     James E. Besser, Managing Member of the General Partner (Name/Title)   Manchester Management Company, LLC*   /s/ James E. Besser
      (Signature)
       
       
      James E. Besser, Managing Member
      (Name/Title)

     

      Manchester Management PR, LLC*   /s/ James E. Besser (Signature)     James E. Besser, Managing Member (Name/Title)  
      JAMES E. BESSER
       
      /s/ James E. Besser
     

    (Signature)

     

    MORGAN C. FRANK

     

    /s/ Morgan C. Frank

    (Signature)

     

     
     

    Exhibit B

     

     

    Schedule of Transactions in Shares

     

     

    Date of Transaction

     

    Title of Class

    Number of Shares Acquired Number of Shares Disposed

    Price Per

    Share

     

             

     

    The Reporting Persons have not transacted in shares of the Issuer since the Schedule 13D/A filed on February 17, 2022.

     

     

     

     

     

     

     

     

     

     

     

    Get the next $MODD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MODD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MODD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Goldberg Jeff D

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/3/25 6:21:17 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Vos Ellen O'Connor

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:34:55 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Sheibley Philip Brent

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:33:46 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Manchester Management Co Llc bought $1,299,997 worth of shares (677,082 units at $1.92) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    3/24/25 9:34:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $35,236 worth of shares (21,000 units at $1.68) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    12/4/24 6:05:34 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $168,950 worth of shares (100,000 units at $1.69) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    11/29/24 10:00:09 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    SEC Filings

    View All

    Modular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Modular Medical, Inc. (0001074871) (Filer)

    9/23/25 8:30:42 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Modular Medical Inc.

    EFFECT - Modular Medical, Inc. (0001074871) (Filer)

    8/20/25 12:15:02 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Modular Medical Inc.

    POS AM - Modular Medical, Inc. (0001074871) (Filer)

    8/13/25 5:29:22 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Modular Medical Announces Licensing and Partnership Agreement With Nudge BG

    -Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG."We are very excited to partner with Modular Medical to bring the next g

    12/19/24 4:01:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Pricing of $8.2 Million Public Offering

    SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has priced an underwritten public offering (the "offering") of 5,450,573 shares of its common stock. The offering was led by existing institutional investors, including Manchester Explorer, L.P., which is the largest shareholder of the Company and is managed by Jeb Besser, Modular Medical's Chief Executive Officer. The shares of common stock are being sold at a price t

    11/21/24 9:15:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Leadership Updates

    Live Leadership Updates

    View All

    Modular Medical Announces Addition to the Russell Microcap(R) Index

    SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalizatio

    6/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors

    SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the appointment of medical device industry leader Duane DeSisto to its board of directors. Mr. DeSisto was previously President, CEO and Director of Insulet Corporation, developers of the groundbreaking OmniPod Insulin Management System, before retiring in 2014."Duane brings more than 25 years of experience in the medical device industry and is a visionary business leader credited with the launch and transformatio

    7/6/23 8:30:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Appoints Kevin Schmid as Chief Operating Officer

    Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabete

    7/26/22 8:15:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Financials

    Live finance-specific insights

    View All

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump

    SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it will hold a conference call and webcast tomorrow, Thursday, September 5, 2024, at 8:30 a.m. Eastern Time to discuss the U. S. Food and Drug Administration ("FDA") clearance of its MODD1 pump, as well as next steps and milestones.Conference Call and Webcast InformationDate: September 5, 2024Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)Conference Call Number: 1-88

    9/4/24 6:57:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

    MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial availability expected in early 2025 SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it has received U. S. Food and Drug Administration ("FDA") clearance to market and sell its MODD1 pump in the United States. With its comme

    9/4/24 4:30:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Modular Medical Inc.

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    11/25/24 7:18:33 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Modular Medical Inc.

    SC 13G - Modular Medical, Inc. (0001074871) (Subject)

    3/1/24 3:48:41 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Modular Medical Inc. (Amendment)

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    2/21/24 5:20:18 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care